Terms: = Head and neck cancer AND PR, PGR, progesterone receptor AND Treatment
768 results:
1. [Clinical efficacy of induction chemoimmunotherapy for locally advanced hypopharyngeal carcinoma: a prospective phase Ⅱ study].
Gong HL; Tian S; Ding H; Tao L; Wang L; Wang J; Wang T; Zhang M; Shi Y; Xu CZ; Wu CP; Wang SZ; Zhou L
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2024 Apr; 59(4):350-356. PubMed ID: 38599645
[No Abstract] [Full Text] [Related]
2. Intratumor tertiary lymphatic structure evaluation predicts the prognosis and immunotherapy response of patients with colorectal cancer.
Feng H; Zhang S; Zhou Q; Han F; Du G; Wang L; Yang X; Zhang X; Yu W; Wei F; Hao X; Ren X; Zhao H
Front Immunol; 2024; 15():1302903. PubMed ID: 38500886
[TBL] [Abstract] [Full Text] [Related]
3. Classification and prediction of chemoradiotherapy response and survival from esophageal carcinoma histopathology images.
Chen Y; Gao R; Jing D; Shi L; Kuang F; Jing R
Spectrochim Acta A Mol Biomol Spectrosc; 2024 May; 312():124030. PubMed ID: 38368818
[TBL] [Abstract] [Full Text] [Related]
4. First-In-Human Phase I Study of Tinengotinib (TT-00420), a Multiple Kinase Inhibitor, as a Single Agent in Patients With Advanced Solid Tumors.
Piha-Paul SA; Xu B; Dumbrava EE; Fu S; Karp DD; Meric-Bernstam F; Hong DS; Rodon JA; Tsimberidou AM; Raghav K; Ajani JA; Conley AP; Mott F; Fan Y; Fan J; Peng P; Wang H; Ni S; Sun C; Qiang X; Levin WJ; Ngo B; Ru QC; Wu F; Javle MM
Oncologist; 2024 Apr; 29(4):e514-e525. PubMed ID: 38297981
[TBL] [Abstract] [Full Text] [Related]
5. The Efficacy of Immunotherapy and Clinical Utility of Comprehensive Genomic Profiling in Adenoid Cystic Carcinoma of head and neck.
Naito T; Noji R; Kugimoto T; Kuroshima T; Tomioka H; Fujiwara S; Suenaga M; Harada H; Kano Y
Medicina (Kaunas); 2023 Dec; 59(12):. PubMed ID: 38138214
[No Abstract] [Full Text] [Related]
6. Phase I Study of mTORC1/2 Inhibitor Sapanisertib (CB-228/TAK-228) in Combination with Metformin in Patients with mTOR/AKT/PI3K Pathway Alterations and Advanced Solid Malignancies.
Subbiah V; Coleman N; Piha-Paul SA; Tsimberidou AM; Janku F; Rodon J; Pant S; Dumbrava EEI; Fu S; Hong DS; Zhang S; Sun M; Jiang Y; Roszik J; Song J; Yuan Y; Meric-Bernstam F; Naing A
Cancer Res Commun; 2024 Feb; 4(2):378-387. PubMed ID: 38126764
[TBL] [Abstract] [Full Text] [Related]
7. Differential Sensitivity to Ionizing Radiation in Gemcitabine-Resistant and Paclitaxel-Resistant Pancreatic cancer Cells.
Che PP; Gregori A; Bergonzini C; Ali M; Mantini G; Schmidt T; Finamore F; Rodrigues SMF; Frampton AE; McDonnell LA; Danen EH; Slotman BJ; Sminia P; Giovannetti E
Int J Radiat Oncol Biol Phys; 2024 Apr; 118(5):1328-1343. PubMed ID: 37914140
[TBL] [Abstract] [Full Text] [Related]
8. Real-world data of immunotherapy from China in recurrent or metastatic head and neck squamous cell carcinoma.
Zhang X; Wang P; Chai Y; Zhou X; Li P; Wang X
Am J Otolaryngol; 2024; 45(1):104065. PubMed ID: 37879241
[TBL] [Abstract] [Full Text] [Related]
9. [Significance of neoadjuvant immunotherapy combined with chemotherapy in the treatment of larynx preservation in locally advanced hypopharyngeal squamous cell carcinoma].
Wu J; Hu G; Li M; Wang Z; Ma W; Wang X; Zhu J; Pan M; Zeng Q
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2023 Sep; 37(9):715-720;728. PubMed ID: 37830119
[No Abstract] [Full Text] [Related]
10. Noninvasive radiomic analysis of enhanced CT predicts CTLA4 expression and prognosis in head and neck squamous cell carcinoma.
Zhu Y; Wu M
Sci Rep; 2023 Oct; 13(1):16782. PubMed ID: 37798374
[TBL] [Abstract] [Full Text] [Related]
11. Safety and clinical efficacy of an anti-PD-L1 antibody (c4G12) in dogs with advanced malignant tumours.
Maekawa N; Konnai S; Hosoya K; Kim S; Kinoshita R; Deguchi T; Owaki R; Tachibana Y; Yokokawa M; Takeuchi H; Kagawa Y; Takagi S; Ohta H; Kato Y; Yamamoto S; Yamamoto K; Suzuki Y; Okagawa T; Murata S; Ohashi K
PLoS One; 2023; 18(10):e0291727. PubMed ID: 37792729
[TBL] [Abstract] [Full Text] [Related]
12. Potential Predictive Immune and Metabolic Biomarkers of Tumor Microenvironment Regarding Pathological and Clinical Response in Esophageal cancer After Neoadjuvant Chemoradiotherapy: A Systematic Review.
Wang HH; Steffens EN; Kats-Ugurlu G; van Etten B; Burgerhof JGM; Hospers GAP; Plukker JTM
Ann Surg Oncol; 2024 Jan; 31(1):433-451. PubMed ID: 37777688
[TBL] [Abstract] [Full Text] [Related]
13. Prognostic value of pretreatment FDG PET-CT for short-term efficacy of radioactive iodine-125 seed implantation in patients with NSCLC.
Hu T; Shen J; Shao M; Feng X; Lu D; Ding E
Brachytherapy; 2023; 22(6):882-888. PubMed ID: 37758577
[TBL] [Abstract] [Full Text] [Related]
14. [Comparison of different laryngeal preservation strategies based on chemoradiotherapy in locally advanced hypopharyngeal carcinoma].
Luo X; Sun S; Xu Y; Huang X; Wang K; Wu R; Wang J; Zhang Y; Zhang J; Chen X; Qu Y; Luo J; Yi J
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2023 Sep; 37(9):708-714. PubMed ID: 37640994
[No Abstract] [Full Text] [Related]
15. The efficacy and safety of sintilimab combined with chemotherapy as the first-line treatment for metastatic esophageal squamous cell carcinoma.
Zhao Z; Yin MM; Zhao WF; Wang CJ
Medicine (Baltimore); 2023 Aug; 102(33):e34794. PubMed ID: 37603519
[TBL] [Abstract] [Full Text] [Related]
16. A new marker constructed from immune-related lncRNA pairs can be used to predict clinical treatment effects and prognosis: in-depth exploration of underlying mechanisms in HNSCC.
Fan X; Huang Y; Zhong Y; Yan Y; Li J; Fan Y; Xie F; Luo Q; Zhang Z
World J Surg Oncol; 2023 Aug; 21(1):250. PubMed ID: 37592311
[TBL] [Abstract] [Full Text] [Related]
17. Photodynamic therapy (PDT) for oral leukoplakia: a systematic review and meta-analysis of single-arm studies examining efficacy and subgroup analyses.
Zhang R; Gao T; Wang D
BMC Oral Health; 2023 Aug; 23(1):568. PubMed ID: 37574560
[TBL] [Abstract] [Full Text] [Related]
18. Surgery-ineligible elderly patients with cutaneous squamous cell carcinoma of the head and neck region gain clinical benefit from definitive weekly hypofractionated radiotherapy.
De Felice F; Serpone M; Cattaneo CG; Di Giammarco F; Fallico A; Delle Donne A; Lanzilao M; Vitti E; Marampon F; Musio D; Tombolini V; Minniti G
Head Neck; 2023 Sep; 45(9):2363-2368. PubMed ID: 37439379
[TBL] [Abstract] [Full Text] [Related]
19. Intrathoracic synovial sarcoma with BRAF V600E mutation.
Russo I; Barresi S; Di Paolo PL; Di Ruscio V; Del Baldo G; Serra A; Vallese S; Miele E; Mastronuzzi A; Alaggio R; Ferrari A; Milano GM
Oncotarget; 2023 Jul; 14():703-708. PubMed ID: 37417899
[TBL] [Abstract] [Full Text] [Related]
20. Sintilimab as maintenance treatment for local/regional recurrent esophageal squamous carcinoma after concurrent chemoradiotherapy: a single-arm Ib/II phase study.
Liu C; Sun H; Huang W; Wang Z; Fu C; Han D; Zhao Q; Wu X; Li B
Front Immunol; 2023; 14():1193394. PubMed ID: 37325650
[TBL] [Abstract] [Full Text] [Related]
[Next]
